albendazole has been researched along with Anguilluliasis in 148 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "A prospective, randomized, open study was conducted in which a 7-day course of oral albendazole 800 mg daily was compared with a single dose (200 microgram/kilogram body weight), or double doses, given 2 weeks apart, of ivermectin in Thai patients with chronic strongyloidiasis." | 9.15 | Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. ( Anekthananon, T; Bhumimuang, K; Karuphong, E; Nilganuwong, S; Premasathian, N; Silpasakorn, S; Suputtamongkol, Y; Wanachiwanawin, D; Waywa, D, 2011) |
| "A prospective, randomised, open study compared a 7-day course of oral albendazole 800 mg daily with a single oral dose of the parenteral veterinary preparation of ivermectin in 42 Thai patients with chronic strongyloidiasis (21 in each group)." | 9.13 | Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis. ( Beeching, NJ; Kungpanichkul, N; Silpasakorn, S; Suputtamongkol, Y, 2008) |
| "A randomized trial study was conducted comparing the efficacy of two high-dose regimens of albendazole for the treatment of uncomplicated human strongyloidiasis." | 9.12 | Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis. ( Intapan, PM; Maleewong, W; Singthong, S; Wongsaroji, T, 2006) |
| "An open randomized study for comparing the efficacy of albendazole and thiabendazole in chronic strongyloidiasis was done in 1990-1992." | 9.08 | A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. ( Chindanond, D; Pitisuttithum, P; Supanaranond, W, 1995) |
| "We reported the efficacy of albendazole (ABZ) for the treatment of 27 patients with strongyloidiasis." | 9.07 | [Clinical study of albendazole therapy for strongyloidiasis]. ( Hirata, T; Kinjo, F; Kouchi, A; Nakamura, H; Niimura, S; Ohshiro, J; Shikiya, K; Uechi, H; Uehara, T; Zaha, O, 1992) |
| "Disseminated strongyloidiasis is often fatal, despite treatment with oral albendazole and parenteral ivermectin (IVM)." | 7.88 | Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy. ( Boodman, C; Charles, M; Chhonker, YS; Grant, J; Libman, M; Mah, A; Murry, DJ; Nishi, C; Steiner, T, 2018) |
| "We succeeded in stimulation of excretion of Strongyloides stercoralis larvae in stool by oral administration of a single dose of 400 mg albendazole to strongyloidiasis patients." | 7.76 | Albendazole stimulates the excretion of strongyloides stercoralis Larvae in stool specimens and enhances sensitivity for diagnosis of strongyloidiasis. ( Anamnart, W; Intapan, PM; Maleewong, W; Pattanawongsa, A, 2010) |
| "The clinical efficacy of albendazole (ABZ) in the treatment of chronic uncomplicated strongyloidiasis has been reported to be highly variable." | 7.68 | The efficacy of two electron transport inhibitors (720C80 and 993C76) on murine strongyloidiasis: a comparison with albendazole. ( Armson, A; Grubb, WB; Mendis, AH; Reynoldson, JA; Thompson, RC, 1993) |
| " We argue the need to define the prevalence threshold to implement preventive chemotherapy for S stercoralis, the target populations and optimal dosing schedules, and discuss the added benefits of a fixed-dose coformulation of ivermectin and albendazole." | 6.82 | Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control. ( Cambra-Pellejà, M; Doyle, SR; Enbiale, W; Escola, V; Gandasegui, J; Hatherell, HA; Kepha, S; Krolewiecki, AJ; Muñoz, J; Onwuchekwa, C; Pullan, RL; van Lieshout, L, 2022) |
| "Eosinophilia was present in 41 of 171 refugees at the first blood draw." | 5.35 | Persistent eosinophilia and Strongyloides infection in Montagnard refugees after presumptive albendazole therapy. ( Corey, GR; Goswami, ND; Shah, JJ; Stout, JE, 2009) |
| " This admission, she was treated with a combination of oral ivermectin (injectable solution form), with a dosage of 200-400 microg/kg/day, and albendazole for 14 days." | 5.32 | Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis. ( Niticharoenpong, K; Pornsuriyasak, P; Sakapibunnan, A, 2004) |
| " The other group (Group II) of 24 received the same dosage but repeated a week later." | 5.28 | Repeated doses of albendazole against strongyloidiasis in Thai children. ( Chanthavanich, P; Nontasut, P; Prarinyanuparp, V; Sa-Nguankiat, S, 1989) |
| "Albendazole was used to treat 30 patients with Strongyloides stercoralis infections." | 5.27 | Albendazole in the treatment of strongyloidiasis. ( Bunnag, D; Chindanond, D; Pungpak, S; Radmoyos, B, 1987) |
| "A prospective, randomized, open study was conducted in which a 7-day course of oral albendazole 800 mg daily was compared with a single dose (200 microgram/kilogram body weight), or double doses, given 2 weeks apart, of ivermectin in Thai patients with chronic strongyloidiasis." | 5.15 | Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis. ( Anekthananon, T; Bhumimuang, K; Karuphong, E; Nilganuwong, S; Premasathian, N; Silpasakorn, S; Suputtamongkol, Y; Wanachiwanawin, D; Waywa, D, 2011) |
| "A prospective, randomised, open study compared a 7-day course of oral albendazole 800 mg daily with a single oral dose of the parenteral veterinary preparation of ivermectin in 42 Thai patients with chronic strongyloidiasis (21 in each group)." | 5.13 | Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis. ( Beeching, NJ; Kungpanichkul, N; Silpasakorn, S; Suputtamongkol, Y, 2008) |
| "A randomized trial study was conducted comparing the efficacy of two high-dose regimens of albendazole for the treatment of uncomplicated human strongyloidiasis." | 5.12 | Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis. ( Intapan, PM; Maleewong, W; Singthong, S; Wongsaroji, T, 2006) |
| " Treatment with ivermectin 78 cases and albendazole 33 cases of strongyloidiasis gave cure rates at 98." | 5.11 | Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole. ( Fongsri, S; Muennoo, C; Nontasut, P; Sa-nguankiat, S; Vichit, A, 2005) |
| "A randomized trial carried out in rural Zanzibar comparing a single dose of 200 micrograms/kg of ivermectin and 400 mg/day for three days of albendazole for treatment of strongyloidiasis and other intestinal nematodes is described." | 5.08 | A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children. ( Ameir, JS; Chwaya, HM; Haji, HJ; Hatz, C; Marti, H; Mgeni, AF; Savioli, L, 1996) |
| "An open randomized study for comparing the efficacy of albendazole and thiabendazole in chronic strongyloidiasis was done in 1990-1992." | 5.08 | A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis. ( Chindanond, D; Pitisuttithum, P; Supanaranond, W, 1995) |
| "We reported the efficacy of albendazole (ABZ) for the treatment of 27 patients with strongyloidiasis." | 5.07 | [Clinical study of albendazole therapy for strongyloidiasis]. ( Hirata, T; Kinjo, F; Kouchi, A; Nakamura, H; Niimura, S; Ohshiro, J; Shikiya, K; Uechi, H; Uehara, T; Zaha, O, 1992) |
| " Albendazole can be beneficial for taeniasis and strongyloidiasis." | 4.83 | [Therapeutic alternatives in case of failure of first-line treatment of intestinal helminthiasis in adults]. ( Debonne, JM; Rey, P, 2006) |
| "Disseminated strongyloidiasis is often fatal, despite treatment with oral albendazole and parenteral ivermectin (IVM)." | 3.88 | Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy. ( Boodman, C; Charles, M; Chhonker, YS; Grant, J; Libman, M; Mah, A; Murry, DJ; Nishi, C; Steiner, T, 2018) |
| "We succeeded in stimulation of excretion of Strongyloides stercoralis larvae in stool by oral administration of a single dose of 400 mg albendazole to strongyloidiasis patients." | 3.76 | Albendazole stimulates the excretion of strongyloides stercoralis Larvae in stool specimens and enhances sensitivity for diagnosis of strongyloidiasis. ( Anamnart, W; Intapan, PM; Maleewong, W; Pattanawongsa, A, 2010) |
| " Our case who has rheumatoid arthritis (RA) and bronchial asthma was treated with low dose steroids and methotrexate." | 3.76 | Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis and bronchial asthma: a case report. ( Altintop, L; Bektas, A; Cakar, B; Hokelek, M; Karaoglanoglu, M; Yildiz, L, 2010) |
| "We report a case of the Mazzotti reaction in a 13-year-old Liberian refugee after presumptive treatment of schistosomiasis and strongyloidiasis with ivermectin, praziquantel and albendazole." | 3.73 | Mazzotti reaction after presumptive treatment for schistosomiasis and strongyloidiasis in a Liberian refugee. ( Domachowske, JB; Olson, BG, 2006) |
| " Serological tests confirmed the diagnosis of pulmonary strongyloidiasis, and both patients were treated with anti-helminthic medications, including albendazole and ivermectin." | 3.72 | Pulmonary strongyloidiasis presenting as chronic bronchitis leading to interlobular septal fibrosis and cured by treatment. ( Carrick, J; Mukerjee, CM; Walker, JC; Woods, RL, 2003) |
| "The clinical efficacy of albendazole (ABZ) in the treatment of chronic uncomplicated strongyloidiasis has been reported to be highly variable." | 3.68 | The efficacy of two electron transport inhibitors (720C80 and 993C76) on murine strongyloidiasis: a comparison with albendazole. ( Armson, A; Grubb, WB; Mendis, AH; Reynoldson, JA; Thompson, RC, 1993) |
| " We argue the need to define the prevalence threshold to implement preventive chemotherapy for S stercoralis, the target populations and optimal dosing schedules, and discuss the added benefits of a fixed-dose coformulation of ivermectin and albendazole." | 2.82 | Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control. ( Cambra-Pellejà, M; Doyle, SR; Enbiale, W; Escola, V; Gandasegui, J; Hatherell, HA; Kepha, S; Krolewiecki, AJ; Muñoz, J; Onwuchekwa, C; Pullan, RL; van Lieshout, L, 2022) |
| "Tribendimidine is an anthelminthic drug with a broad spectrum of activity." | 2.73 | Tribendimidine and albendazole for treating soil-transmitted helminths, Strongyloides stercoralis and Taenia spp.: open-label randomized trial. ( Du, ZW; Jiang, JY; Steinmann, P; Utzinger, J; Wu, ZX; Xiao, SH; Zhou, H; Zhou, XN, 2008) |
| "He developed acute respiratory failure and progressed to diffuse alveolar hemorrhage owing to disseminated strongyloidiasis immediately." | 2.53 | A Fatal Strongyloides Stercoralis Hyperinfection Syndrome in a Patient With Chronic kidney Disease: A Case Report and Literature Review. ( Qu, TT; Wang, J; Yang, Q; Yu, MH, 2016) |
| "Strongyloidiasis is a gut infection with Strongyloides stercoralis which is common world wide." | 2.53 | Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection. ( Echevarria, J; Gotuzzo, E; Henriquez-Camacho, C; Pérez-Molina, JA; Plana, MN; Samalvides, F; Terashima, A; White, AC, 2016) |
| "Eosinophilia is a common finding in international travelers and immigrants, being an helmintic infection its main etiology." | 2.53 | [Clinical approach to imported eosinophilia]. ( Álvarez-Martínez, D; Bosh-Guerra, X; Cañas García-Otero, E; Cisneros-Herreros, JM; Praena-Segovia, J; Ruiz-Pérez de Pipaón, M; Sánchez-Agüera, M, 2016) |
| "Strongyloidiasis is an infection caused by the intestinal nematode Strongyloides stercoralis." | 2.48 | Symptomatic chronic strongyloidiasis in children following treatment for solid organ malignancies: case reports and literature review. ( Abdelrahman, Z; Ariffin, N; Madihah, B; Norsarwany, M; Norsyahida, A; Rahmah, N; Zeehaida, M, 2012) |
| "Hovewer, strongyloidiasis is difficult to diagnose since the parasite load is low and the larval output is irregular in majority of the patients." | 2.45 | [An overview of Strongyloides stercoralis and its infections]. ( Ardiç, N, 2009) |
| "Thiabendazole has been replaced by ivermectin as treatment of choice due to better tolerance." | 2.44 | Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection. ( Segarra-Newnham, M, 2007) |
| "ENDEMIC ZONES: Strongyloidiasis is an intestinal parasitosis which is frequently found in tropical and subtropical regions." | 2.41 | [Disseminated strongyloidiasis]. ( Danis, M; Datry, A; Nozais, JP; Thellier, M, 2001) |
| "Sepsis and meningitis are frequent." | 2.38 | [Systemic strongyloidiasis. Review]. ( Chacín-Bonilla, L, 1991) |
| "Herein, we present a rare case of a type II diabetes mellitus (T2DM) patient presented with gastrointestinal hemorrhage and sepsis caused by concomitant Strongyloides stercoralis and cytomegalovirus (CMV) infection." | 1.91 | Strongyloides hyperinfection syndrome and cytomegalovirus infection in a patient with type II diabetes mellitus. ( Guo, J; Liu, J; Wang, Z, 2023) |
| " In the case of hyperinfection, repeated doses are recommended up to 2 weeks after clearance of larvae from biological fluids, with close monitoring and further dosing based on review." | 1.72 | Current pharmacotherapeutic strategies for Strongyloidiasis and the complications in its treatment. ( Barda, B; Buonfrate, D; Einsiedel, L; Page, W; Rodari, P; Watts, MR, 2022) |
| "Albendazole was added for adjunctive therapy." | 1.72 | Strongyloides stercoralis hyperinfection syndrome: a known entity in an unknown provenance. ( Calderon Candelario, RA; Kett, DH; Naidu, YV, 2022) |
| "CNS involvement in strongyloidiasis has only been seen in patients with hyperinfestation syndrome and may be fatal when misdiagnosed." | 1.56 | Central Nervous System Strongyloides Stercoralis. A Case Report. ( Demirtas, E; Oktar, N; Ozer, HM, 2020) |
| "Strongyloidiasis is a disease caused by the nematode Strongyloides stercoralis that is endemic in rural regions in tropical and subtropical countries." | 1.56 | Subcutaneous ivermectin for the treatment of the hyperinfection syndrome by Strongyloides stercoralis ( Ballesteros, ÓA; Guevara, FO; Hennessey, DC; Merchán, DJ; Severiche, DF, 2020) |
| "Imported strongyloidiasis is increasingly being diagnosed in non-endemic areas." | 1.51 | Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish Collaborative Network (2009-2017). ( Chamorro-Tojeiro, S; Goikoetxea, J; Herrero-Martínez, JM; López-Vélez, R; Molina, I; Pérez-Molina, JA; Rodríguez-Guardado, A; Salvador, F; Sánchez-Montalvá, A; Serre-Delcor, N; Sulleiro, E; Torrús, D; Treviño, B; Velasco, M; Zubero, Z, 2019) |
| "Hypereosinophilic syndromes are rare in children." | 1.51 | Hypereosinophilia and severe bone disease in an African child: an unexpected diagnosis. ( Alves, P; Bota, S; Constantino, C; Maia, R, 2019) |
| " Moxidectin (routinely dosed at 0." | 1.48 | Effectiveness of several anthelmintics to control a Strongyloides sp. outbreak in Creole-de-Guadeloupe male kids aged 7 months. ( Arquet, R; Mahieu, M; Marie-Magdeleine, C, 2018) |
| "Strongyloidiasis is an infection caused by the parasite Strongyloides stercoralis, which can be asymptomatic and means a high morbidity and mortality in immunocompromised hosts, severe malnutrition and coinfection with HTLV-1 virus." | 1.43 | [Pulmonary strongyloidiasis]. ( Daza, JE; Lozada, H, 2016) |
| "After post-operative imatinib treatment eosinophilia persisted, so that steroid therapy was started under an impression of hypereosinophilic syndrome." | 1.42 | Strongyloidiasis in a diabetic patient accompanied by gastrointestinal stromal tumor: cause of eosinophilia unresponsive to steroid therapy. ( Jeon, J; Koh, YI; Ryang, DW; Won, EJ, 2015) |
| "Shortly thereafter, she developed acute respiratory failure and progressed to acute respiratory distress syndrome and septic shock." | 1.42 | Diffuse alveolar haemorrhage and severe hypoxemia from Strongyloides stercoralis hyperinfection syndrome. ( Al Maashari, R; Beejay, N; El-Sameed, YA, 2015) |
| "Strongyloidiasis is a nematode-borne disease caused by several Strongyloides species." | 1.39 | [Strongyloides stercoralis in a patient with ankylosing spondylitis: case report]. ( Altıntop, L; Hökelek, M; Karadağ, A; Odabaşı, H; Unal, N; Yanık, K, 2013) |
| "The diagnosis of strongyloidiasis is sometimes difficult to establish due to the fact that eosinophilia may be absent, while commonly utilized stool examinations may be negative." | 1.39 | "Surprise" in the evolution of chronic membranoproliferative glomerulonephritis associated with severe strongyloidiasis under corticotherapy: "hygienic paradox"? ( Bozdog, G; Gluhovschi, C; Gluhovschi, G; Petrica, L; Ratiu, I; Taban, S; Velciov, S, 2013) |
| "Serologic testing for chronic parasitic infections is often necessary." | 1.35 | Eosinophilia in a patient from South America. ( Page, KR; Zenilman, J, 2008) |
| "Eosinophilia was present in 41 of 171 refugees at the first blood draw." | 1.35 | Persistent eosinophilia and Strongyloides infection in Montagnard refugees after presumptive albendazole therapy. ( Corey, GR; Goswami, ND; Shah, JJ; Stout, JE, 2009) |
| "Strongyloidiasis is caused by a small intestinal nematode with a complex life cycle." | 1.34 | [Nephrotic syndrome and Gram-negative sepsis in a patient with strongyloidiasis: a case report]. ( Bono, L; Coglitore, M; Faraci, C; Giordano, S; Infurnari, L; Romano, A; Rotolo, U; Rubino, R; Scarlata, F; Tortorici, C, 2007) |
| " There were no significant differences in the type of immunocompromized host and the corticosteroid dosage between the two groups (p > 0." | 1.33 | Risk factors for strongyloidiasis hyperinfection and clinical outcomes. ( Asdamongkol, N; Pornsuriyasak, P; Sungkanuparph, S, 2006) |
| " Prolonged treatment with ivermectin in a dosage exceeding the current recommendations may be required in HTLV-1 infected patients and was well tolerated." | 1.33 | [Recurrent strongyloidiasis as an indicator of HTLV-1 infection]. ( Duwe, S; Ellerbrok, H; Pauli, G; Poggensee, G; Richter, J; Schwarz, U, 2005) |
| "Eosinophilia was most strongly associated with entering the enemy camp and being in the platoon that attacked the area around the camp latrines." | 1.33 | Helminth infections in British troops following an operation in Sierra Leone. ( Bailey, JW; Bailey, MS; Beeching, NJ; Green, AD; Thomas, R, 2006) |
| " This admission, she was treated with a combination of oral ivermectin (injectable solution form), with a dosage of 200-400 microg/kg/day, and albendazole for 14 days." | 1.32 | Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis. ( Niticharoenpong, K; Pornsuriyasak, P; Sakapibunnan, A, 2004) |
| "The effect of coinfection on HIV disease progression varied with species." | 1.32 | Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda. ( Brown, M; Elliott, AM; Hughes, P; Kizza, M; Quigley, MA; Rowland, S; Watera, C; Whitworth, JA, 2004) |
| "When mebendazole was given at 100 mg twice daily for 3 days, its effectiveness was 88." | 1.31 | Strongyloides stercoralis infection and chronological changes of other soil-transmitted helminthiases in an endemic area of southern Thailand. ( Anantaphruti, MT; Muennoo, C; Nuamtanong, S; Pubampen, S; Sanguankiat, S, 2000) |
| "Strongyloidiasis is an parasitic intestinal disease, frequent in tropical countries and fairly rare in temperate areas under certain conditions." | 1.31 | [Disseminated strongyloidiasis, a rare cause of multiple organ failure]. ( Daoudal, P; Desbois, N; Numeric, P; Ramialison, C; Ribier, G, 2002) |
| "Albendazole was given (2 x 400 mg daily for 6 days, followed by a maintenance dose of 1 x 400 mg daily)." | 1.30 | [Strongyloides stercoralis infection in a patient with AIDS and non-Hodgkin lymphoma]. ( Diehl, V; Fätkenheuer, G; Franzen, C; Müller, A; Salzberger, B; Schrappe, M, 1998) |
| "Strongyloidiasis has been recognized as one of the life-threatening parasitic infections in the immunocompromised patients." | 1.30 | A case of Strongyloides stercoralis infection. ( Han, JH; Hong, SJ, 1999) |
| " The patients, 7 males and 2 females aged between 50 and 70, either had the history of long term use of steroids for management of arthritis, or were complicated with other chronic diseases such as hypertension, liver diseases, psychotic disorders, and gastrointestinal problems." | 1.29 | [Nine cases of strongyloidiasis in Korea]. ( Chai, JY; Hong, ST; Khang, SK; Kook, J; Lee, SH; Lee, SK; Shin, BM, 1994) |
| "Strongyloidiasis is a parasitic disease of tropical regions and to some extent of the South of Europe." | 1.28 | [Strongyloidiasis under immunosuppressive therapy]. ( Hanck, C; Holzer, BR, 1992) |
| " The other group (Group II) of 24 received the same dosage but repeated a week later." | 1.28 | Repeated doses of albendazole against strongyloidiasis in Thai children. ( Chanthavanich, P; Nontasut, P; Prarinyanuparp, V; Sa-Nguankiat, S, 1989) |
| " When the drug was given in the same dosage to immunosuppressed dogs with patent infections, the larvae disappeared from the stools transiently; when the animals were killed seven weeks after treatment, small numbers of adult worms and rhabditiform larvae were found in the gut." | 1.27 | Efficacy of albendazole against Strongyloides ratti and S. stercoralis in vitro, in mice, and in normal and immunosuppressed dogs. ( Grove, DI; Lumsden, J; Northern, C, 1988) |
| "The albendazole was well tolerated and no side effects were imputed to the treatment." | 1.27 | Treatment of strongyloides stercoralis with albendazole. A cure rate of 86 per cent. ( Mojon, M; Nielsen, PB, 1987) |
| "Albendazole was used to treat 30 patients with Strongyloides stercoralis infections." | 1.27 | Albendazole in the treatment of strongyloidiasis. ( Bunnag, D; Chindanond, D; Pungpak, S; Radmoyos, B, 1987) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (6.76) | 18.7374 |
| 1990's | 22 (14.86) | 18.2507 |
| 2000's | 52 (35.14) | 29.6817 |
| 2010's | 52 (35.14) | 24.3611 |
| 2020's | 12 (8.11) | 2.80 |
| Authors | Studies |
|---|---|
| Ashiri, A | 1 |
| Rafiei, A | 1 |
| Beiromvand, M | 1 |
| Khanzadeh, A | 1 |
| Alghasi, A | 1 |
| Naidu, YV | 1 |
| Calderon Candelario, RA | 1 |
| Kett, DH | 1 |
| Gandasegui, J | 1 |
| Onwuchekwa, C | 1 |
| Krolewiecki, AJ | 2 |
| Doyle, SR | 1 |
| Pullan, RL | 1 |
| Enbiale, W | 1 |
| Kepha, S | 1 |
| Hatherell, HA | 1 |
| van Lieshout, L | 1 |
| Cambra-Pellejà, M | 1 |
| Escola, V | 1 |
| Muñoz, J | 1 |
| Buonfrate, D | 2 |
| Rodari, P | 1 |
| Barda, B | 1 |
| Page, W | 2 |
| Einsiedel, L | 1 |
| Watts, MR | 1 |
| Pedersen, AA | 1 |
| Hartmeyer, GN | 1 |
| Stensvold, CR | 1 |
| Martin-Iguacel, R | 1 |
| Wang, Z | 1 |
| Guo, J | 1 |
| Liu, J | 1 |
| Sankar, J | 1 |
| Gupta, S | 1 |
| Lingaiah, R | 1 |
| Ross, SA | 1 |
| Pintilie, H | 1 |
| Hatcher, J | 1 |
| Dosekun, O | 1 |
| Cooke, GS | 1 |
| Bailey, AC | 1 |
| Nazik, S | 1 |
| Yıldız, F | 1 |
| Hennessey, DC | 1 |
| Ballesteros, ÓA | 1 |
| Merchán, DJ | 1 |
| Guevara, FO | 1 |
| Severiche, DF | 1 |
| Ofosu, A | 1 |
| Higgins, J | 1 |
| Frye, JS | 1 |
| Kumari, R | 1 |
| Barakat, MT | 1 |
| Osiro, S | 1 |
| Hamula, C | 1 |
| Glaser, A | 1 |
| Rana, M | 1 |
| Dunn, D | 1 |
| Echazú, A | 1 |
| Juarez, M | 1 |
| Vargas, PA | 1 |
| Cajal, SP | 1 |
| Cimino, RO | 1 |
| Heredia, V | 1 |
| Caropresi, S | 1 |
| Paredes, G | 1 |
| Arias, LM | 1 |
| Abril, M | 1 |
| Gold, S | 1 |
| Lammie, P | 1 |
| Martinez-Perez, A | 1 |
| Roure Díez, S | 1 |
| Belhassen-Garcia, M | 1 |
| Torrús-Tendero, D | 1 |
| Perez-Arellano, JL | 1 |
| Cabezas, T | 1 |
| Soler, C | 1 |
| Díaz-Menéndez, M | 1 |
| Navarro, M | 1 |
| Treviño, B | 2 |
| Salvador, F | 2 |
| Rego Silva, J | 1 |
| Macau, RA | 1 |
| Mateus, A | 1 |
| Cruz, P | 1 |
| Aleixo, MJ | 1 |
| Brito, M | 1 |
| Alcobia, A | 1 |
| Oliveira, C | 1 |
| Ramos, A | 1 |
| Barreto, NMPV | 1 |
| de Souza, JN | 1 |
| Araújo, WAC | 1 |
| Khouri, NA | 1 |
| de Oliveira, EP | 1 |
| Teixeira, MCA | 1 |
| Soares, NM | 1 |
| Boodman, C | 1 |
| Chhonker, YS | 1 |
| Murry, DJ | 1 |
| Mah, A | 1 |
| Grant, J | 1 |
| Steiner, T | 1 |
| Libman, M | 1 |
| Nishi, C | 1 |
| Charles, M | 1 |
| Miskovic, R | 1 |
| Plavsic, A | 1 |
| Bolpacic, J | 1 |
| Raskovic, S | 1 |
| Ranin, J | 1 |
| Bogic, M | 1 |
| Moussouni, L | 1 |
| Benhanifia, M | 1 |
| Ayad, A | 1 |
| Oktar, N | 1 |
| Ozer, HM | 1 |
| Demirtas, E | 1 |
| Mahieu, M | 1 |
| Arquet, R | 1 |
| Marie-Magdeleine, C | 1 |
| Bota, S | 1 |
| Alves, P | 1 |
| Constantino, C | 1 |
| Maia, R | 1 |
| Chamorro-Tojeiro, S | 1 |
| Sánchez-Montalvá, A | 1 |
| Herrero-Martínez, JM | 1 |
| Rodríguez-Guardado, A | 1 |
| Serre-Delcor, N | 1 |
| Torrús, D | 1 |
| Goikoetxea, J | 1 |
| Zubero, Z | 1 |
| Velasco, M | 1 |
| Sulleiro, E | 1 |
| Molina, I | 1 |
| López-Vélez, R | 1 |
| Pérez-Molina, JA | 2 |
| Ntsame Ngoua, S | 1 |
| Iba-Ba, J | 1 |
| Igala, M | 1 |
| Itoudi Bignoumba, PE | 1 |
| Pemba, L | 1 |
| Nziengui Madjinou, MIC | 1 |
| Ledaga, L | 1 |
| Missounga, L | 1 |
| Malekou, D | 1 |
| Boguikouma, JB | 1 |
| Balkhair, A | 1 |
| Taher, HB | 1 |
| Al Busaidi, I | 1 |
| Al Amin, M | 1 |
| Al-Khirbash, A | 1 |
| Al Adawi, B | 1 |
| Al-Siyabi, T | 1 |
| Ekmekci, ÖÖ | 1 |
| Tahmaz, M | 1 |
| Altıparmak, S | 1 |
| Gülaçtı, G | 1 |
| Ergen, AK | 1 |
| Kumbasar, AB | 1 |
| Sepetcioğlu, S | 1 |
| Öner, YA | 1 |
| Yap, P | 2 |
| Du, ZW | 3 |
| Wu, FW | 2 |
| Jiang, JY | 3 |
| Chen, R | 2 |
| Zhou, XN | 3 |
| Hattendorf, J | 1 |
| Utzinger, J | 3 |
| Steinmann, P | 3 |
| Sammet, S | 1 |
| Wieser, A | 1 |
| Müller, S | 1 |
| Huber, M | 1 |
| Schubert, S | 1 |
| Seybold, U | 1 |
| Gluhovschi, G | 1 |
| Gluhovschi, C | 1 |
| Velciov, S | 1 |
| Ratiu, I | 1 |
| Bozdog, G | 1 |
| Taban, S | 1 |
| Petrica, L | 1 |
| Roseman, DA | 1 |
| Kabbani, D | 1 |
| Kwah, J | 1 |
| Bird, D | 1 |
| Ingalls, R | 1 |
| Gautam, A | 1 |
| Nuhn, M | 1 |
| Francis, JM | 1 |
| Yanık, K | 1 |
| Karadağ, A | 1 |
| Odabaşı, H | 1 |
| Unal, N | 1 |
| Altıntop, L | 2 |
| Hökelek, M | 2 |
| Saraei, M | 1 |
| Hosseinbigi, B | 1 |
| Shahnazi, M | 1 |
| Bijani, B | 1 |
| El-Sameed, YA | 1 |
| Beejay, N | 1 |
| Al Maashari, R | 1 |
| Cabada, MM | 1 |
| Lopez, M | 1 |
| Arque, E | 1 |
| Clinton White, A | 1 |
| Giuseppe, S | 1 |
| Francesco, C | 1 |
| Socrate, P | 1 |
| Doriana, V | 1 |
| Carlo, S | 1 |
| Pierluigi, C | 1 |
| Mounsey, K | 1 |
| Kearns, T | 1 |
| Rampton, M | 1 |
| Llewellyn, S | 1 |
| King, M | 1 |
| Holt, D | 1 |
| Currie, BJ | 1 |
| Andrews, R | 1 |
| Nutman, T | 1 |
| McCarthy, J | 2 |
| Chen, JX | 1 |
| Zhou, H | 2 |
| Abdalhamid, BA | 1 |
| Al Abadi, AN | 1 |
| Al Saghier, MI | 1 |
| Joudeh, AA | 1 |
| Shorman, MA | 1 |
| Amr, SS | 1 |
| Seo, AN | 1 |
| Goo, YK | 1 |
| Chung, DI | 1 |
| Hong, Y | 1 |
| Kwon, O | 1 |
| Bae, HI | 1 |
| Nampijja, M | 1 |
| Webb, EL | 1 |
| Kaweesa, J | 1 |
| Kizindo, R | 1 |
| Namutebi, M | 1 |
| Nakazibwe, E | 1 |
| Oduru, G | 1 |
| Kabuubi, P | 1 |
| Kabagenyi, J | 1 |
| Kizito, D | 1 |
| Muhangi, L | 1 |
| Akello, M | 1 |
| Verweij, JJ | 1 |
| Nerima, B | 1 |
| Tukahebwa, E | 1 |
| Elliott, AM | 2 |
| Won, EJ | 1 |
| Jeon, J | 1 |
| Koh, YI | 1 |
| Ryang, DW | 1 |
| Sanches, BF | 1 |
| Morgado, J | 1 |
| Carvalho, N | 1 |
| Anjos, R | 1 |
| Ramli, I | 1 |
| Amarouch, H | 1 |
| Mael-Ainin, M | 1 |
| Aitourhroui, M | 1 |
| Senouci, K | 1 |
| Hassam, B | 1 |
| Boscá Watts, MM | 1 |
| Marco Marqués, A | 1 |
| Savall-Núñez, E | 1 |
| Artero-Fullana, A | 1 |
| Lanza Reynolds, B | 1 |
| Andrade Gamarra, V | 1 |
| Puglia Santos, V | 1 |
| Burgués Gasión, O | 1 |
| Mora Miguel, F | 1 |
| Anuradha, R | 1 |
| Munisankar, S | 1 |
| Bhootra, Y | 1 |
| Jagannathan, J | 1 |
| Dolla, C | 1 |
| Kumaran, P | 1 |
| Nutman, TB | 1 |
| Babu, S | 1 |
| Henriquez-Camacho, C | 1 |
| Gotuzzo, E | 1 |
| Echevarria, J | 1 |
| White, AC | 1 |
| Terashima, A | 1 |
| Samalvides, F | 1 |
| Plana, MN | 1 |
| Gobbi, F | 1 |
| Qu, TT | 1 |
| Yang, Q | 1 |
| Yu, MH | 1 |
| Wang, J | 1 |
| Kumar, A | 2 |
| Nautsch, D | 1 |
| Choksi, TT | 1 |
| Madison, G | 1 |
| Dar, T | 1 |
| Asif, M | 1 |
| Fleming, K | 1 |
| Clarke, L | 1 |
| Danilewitz, M | 1 |
| Hennawy, R | 1 |
| Cañas García-Otero, E | 1 |
| Praena-Segovia, J | 1 |
| Ruiz-Pérez de Pipaón, M | 1 |
| Bosh-Guerra, X | 1 |
| Sánchez-Agüera, M | 1 |
| Álvarez-Martínez, D | 1 |
| Cisneros-Herreros, JM | 1 |
| Lozada, H | 1 |
| Daza, JE | 1 |
| Henao-Martínez, AF | 1 |
| Madinger, N | 1 |
| Pasha, Y | 1 |
| Pickard, L | 1 |
| Cohen, P | 1 |
| Banks, M | 1 |
| Tamer, GS | 1 |
| Dündar, D | 1 |
| Xiao, SH | 1 |
| Wu, ZX | 1 |
| Moser, R | 1 |
| Auer, H | 1 |
| Prenner-Glas, C | 1 |
| Klein, G | 1 |
| Kia, EB | 1 |
| Rahimi, HR | 1 |
| Mirhendi, H | 1 |
| Nilforoushan, MR | 1 |
| Talebi, A | 1 |
| Zahabiun, F | 1 |
| Kazemzadeh, H | 1 |
| Meamar, AR | 1 |
| Lichtenberger, P | 1 |
| Rosa-Cunha, I | 1 |
| Morris, M | 1 |
| Nishida, S | 1 |
| Akpinar, E | 1 |
| Gaitan, J | 1 |
| Tzakis, A | 1 |
| Doblecki-Lewis, S | 1 |
| Balagopal, A | 1 |
| Mills, L | 1 |
| Shah, A | 1 |
| Subramanian, A | 1 |
| Aregawi, D | 1 |
| Lopez, D | 1 |
| Wick, M | 1 |
| Scheld, WM | 1 |
| Schiff, D | 1 |
| Ardiç, N | 1 |
| Huston, JM | 1 |
| Eachempati, SR | 1 |
| Rodney, JR | 1 |
| Cayci, C | 1 |
| Fusco, D | 1 |
| Mathew, M | 1 |
| Shou, J | 1 |
| Goldstein, MJ | 1 |
| Kapur, S | 1 |
| Barie, PS | 1 |
| Goswami, ND | 1 |
| Shah, JJ | 1 |
| Corey, GR | 1 |
| Stout, JE | 1 |
| Rodriguez-Hernandez, MJ | 1 |
| Ruiz-Perez-Pipaon, M | 1 |
| Cañas, E | 1 |
| Bernal, C | 1 |
| Gavilan, F | 1 |
| Arlet, JB | 1 |
| Varet, B | 1 |
| Hermine, O | 1 |
| Capron, L | 1 |
| Pouchot, J | 1 |
| Chiche, L | 1 |
| Dalia, S | 1 |
| Colvin, GA | 1 |
| Anamnart, W | 1 |
| Pattanawongsa, A | 1 |
| Intapan, PM | 2 |
| Maleewong, W | 2 |
| Cakar, B | 1 |
| Bektas, A | 1 |
| Yildiz, L | 1 |
| Karaoglanoglu, M | 1 |
| Li Cavoli, G | 1 |
| Tortorici, C | 2 |
| Bono, L | 2 |
| Ferrantelli, A | 1 |
| Giammarresi, C | 1 |
| Rotolo, U | 2 |
| Suputtamongkol, Y | 2 |
| Premasathian, N | 1 |
| Bhumimuang, K | 1 |
| Waywa, D | 1 |
| Nilganuwong, S | 1 |
| Karuphong, E | 1 |
| Anekthananon, T | 1 |
| Wanachiwanawin, D | 1 |
| Silpasakorn, S | 2 |
| Villena-Ruiz, MÁ | 1 |
| Arboleda-Sánchez, JA | 1 |
| Del Arco-Jiménez, A | 1 |
| Fernandez-Sánchez, F | 1 |
| Dimitrijević, B | 1 |
| Borozan, S | 1 |
| Katić-Radivojević, S | 1 |
| Stojanović, S | 1 |
| Korkmaz, U | 1 |
| Duman, AE | 1 |
| Gurkan, B | 1 |
| Sirin, G | 1 |
| Topcu, Y | 1 |
| Dindar, G | 1 |
| Gurbuz, Y | 1 |
| Senturk, O | 1 |
| Norsarwany, M | 1 |
| Abdelrahman, Z | 1 |
| Rahmah, N | 1 |
| Ariffin, N | 1 |
| Norsyahida, A | 1 |
| Madihah, B | 1 |
| Zeehaida, M | 1 |
| Shea, YF | 1 |
| Chau, KM | 1 |
| Hung, IF | 1 |
| Chu, LW | 1 |
| Daoudal, P | 1 |
| Ribier, G | 1 |
| Numeric, P | 1 |
| Desbois, N | 1 |
| Ramialison, C | 1 |
| Penalva, JC | 1 |
| Sáez, J | 1 |
| Carnicer, F | 1 |
| Griño, P | 1 |
| Company, L | 1 |
| Laveda, R | 1 |
| De la Rosa, GR | 1 |
| Kuliev, A | 1 |
| Barnett, BJ | 1 |
| Lin, JX | 1 |
| Chen, BJ | 1 |
| Zhang, RX | 1 |
| Kim, J | 1 |
| Joo, HS | 1 |
| Kim, DH | 1 |
| Lim, H | 1 |
| Kang, YH | 1 |
| Kim, MS | 1 |
| Mukerjee, CM | 1 |
| Carrick, J | 1 |
| Walker, JC | 1 |
| Woods, RL | 1 |
| Brown, M | 1 |
| Kizza, M | 1 |
| Watera, C | 1 |
| Quigley, MA | 1 |
| Rowland, S | 1 |
| Hughes, P | 1 |
| Whitworth, JA | 1 |
| Muennig, P | 1 |
| Pallin, D | 1 |
| Challah, C | 1 |
| Khan, K | 1 |
| Pornsuriyasak, P | 2 |
| Niticharoenpong, K | 1 |
| Sakapibunnan, A | 1 |
| Richter, J | 1 |
| Schwarz, U | 1 |
| Duwe, S | 1 |
| Ellerbrok, H | 1 |
| Poggensee, G | 1 |
| Pauli, G | 1 |
| Nontasut, P | 2 |
| Muennoo, C | 2 |
| Sa-nguankiat, S | 2 |
| Fongsri, S | 1 |
| Vichit, A | 1 |
| Johnston, FH | 1 |
| Morris, PS | 1 |
| Speare, R | 1 |
| Currie, B | 1 |
| Ewald, D | 1 |
| Dempsey, K | 2 |
| Gill, GV | 2 |
| Beeching, N | 1 |
| Sahoo, PK | 1 |
| Satapathy, AK | 1 |
| Michael, E | 1 |
| Ravindran, B | 1 |
| Turner, SA | 1 |
| Maclean, JD | 1 |
| Fleckenstein, L | 1 |
| Greenaway, C | 1 |
| Leang, B | 1 |
| Lynen, L | 1 |
| Schrooten, W | 1 |
| Hines, J | 1 |
| Bailey, MS | 1 |
| Thomas, R | 1 |
| Green, AD | 1 |
| Bailey, JW | 2 |
| Beeching, NJ | 3 |
| Page, WA | 1 |
| McCarthy, JS | 1 |
| Olson, BG | 1 |
| Domachowske, JB | 1 |
| San Miguel-Fraile, P | 1 |
| Vasallo, FJ | 1 |
| Rodríguez-Conde, I | 1 |
| Ortiz-Rey, JA | 1 |
| Soroczan, W | 1 |
| Kołodziejczyk, L | 1 |
| Sulzyc-Bielicka, V | 1 |
| Kuźna-Grygiel, W | 1 |
| Bielicki, D | 1 |
| Stepień-Korzonek, M | 1 |
| Szmatłoch, E | 1 |
| Rey, P | 1 |
| Debonne, JM | 1 |
| Culha, G | 1 |
| Savaş, L | 1 |
| Onlen, Y | 1 |
| Asdamongkol, N | 1 |
| Sungkanuparph, S | 1 |
| Scarlata, F | 1 |
| Giordano, S | 1 |
| Coglitore, M | 1 |
| Faraci, C | 1 |
| Infurnari, L | 1 |
| Rubino, R | 1 |
| Romano, A | 1 |
| Singthong, S | 1 |
| Wongsaroji, T | 1 |
| Rehman, JU | 1 |
| Rao, TV | 1 |
| AlKindi, S | 1 |
| Dennison, D | 1 |
| Pathare, AV | 1 |
| Rajapurkar, M | 1 |
| Hegde, U | 1 |
| Rokhade, M | 1 |
| Gang, S | 1 |
| Gohel, K | 1 |
| Segarra-Newnham, M | 1 |
| Kungpanichkul, N | 1 |
| Page, KR | 1 |
| Zenilman, J | 1 |
| Morel, R | 1 |
| Ekanayake, S | 1 |
| Abeykoon, S | 1 |
| Turhan, V | 1 |
| Coban, M | 1 |
| Oncül, O | 1 |
| Cavuşlu, S | 1 |
| Rossignol, JF | 3 |
| Maisonneuve, H | 1 |
| Pene, P | 1 |
| Mojon, M | 3 |
| Garin, JP | 1 |
| Coulaud, JP | 2 |
| Erb, HN | 1 |
| Georgi, JR | 1 |
| Deluol, AM | 1 |
| Cenac, J | 1 |
| Nandy, A | 1 |
| Addy, M | 1 |
| Patra, P | 1 |
| Bandyopashyay, AK | 1 |
| Risse, JH | 1 |
| Adam, G | 1 |
| Langen, HJ | 1 |
| Biesterfeld, S | 1 |
| Hoffmann, R | 1 |
| Lee, SK | 1 |
| Shin, BM | 1 |
| Khang, SK | 1 |
| Chai, JY | 2 |
| Kook, J | 2 |
| Hong, ST | 1 |
| Lee, SH | 2 |
| Liu, LX | 1 |
| Weller, PF | 1 |
| Armson, A | 1 |
| Thompson, RC | 1 |
| Reynoldson, JA | 1 |
| Grubb, WB | 1 |
| Mendis, AH | 1 |
| Archibald, LK | 1 |
| Bell, DR | 1 |
| Marti, H | 1 |
| Haji, HJ | 1 |
| Savioli, L | 1 |
| Chwaya, HM | 1 |
| Mgeni, AF | 1 |
| Ameir, JS | 1 |
| Hatz, C | 1 |
| Bassetti, S | 1 |
| Pitisuttithum, P | 1 |
| Supanaranond, W | 1 |
| Chindanond, D | 2 |
| Sreenivas, DV | 1 |
| Kumar, YR | 1 |
| Bharavi, C | 1 |
| Sundaram, C | 1 |
| Gayathri, K | 1 |
| Venkatesan, P | 1 |
| Müller, A | 1 |
| Fätkenheuer, G | 1 |
| Salzberger, B | 1 |
| Schrappe, M | 1 |
| Diehl, V | 1 |
| Franzen, C | 1 |
| Hong, SJ | 1 |
| Han, JH | 1 |
| Kitchen, LW | 1 |
| Mitre, E | 1 |
| Satoh, M | 2 |
| Toma, H | 4 |
| Sato, Y | 4 |
| Kikuchi, M | 1 |
| Takara, M | 4 |
| Shiroma, Y | 3 |
| Kiyuna, S | 2 |
| Hirayama, K | 2 |
| Magnaval, JF | 1 |
| Kobayashi, J | 2 |
| Shimabukuro, I | 2 |
| Anantaphruti, MT | 1 |
| Nuamtanong, S | 1 |
| Sanguankiat, S | 1 |
| Pubampen, S | 1 |
| Tasaki, T | 1 |
| Pretel Serrano, L | 1 |
| Page del Pozo, MA | 1 |
| Ramos Guevara, MR | 1 |
| Ramos Rincón, JM | 1 |
| Martínez Toldos, MC | 1 |
| Herrero Huerta, F | 1 |
| Nozais, JP | 1 |
| Thellier, M | 1 |
| Datry, A | 1 |
| Danis, M | 1 |
| Ron, IG | 1 |
| Berger, S | 1 |
| Inbar, MJ | 1 |
| Chaitchik, S | 1 |
| Siegman-Igra, Y | 1 |
| Kim, SY | 1 |
| Kim, NY | 1 |
| Lee, KH | 1 |
| Park, SH | 1 |
| Gu, MS | 1 |
| Niimura, S | 1 |
| Hirata, T | 1 |
| Zaha, O | 1 |
| Nakamura, H | 1 |
| Kouchi, A | 1 |
| Uehara, T | 1 |
| Uechi, H | 1 |
| Ohshiro, J | 1 |
| Shikiya, K | 1 |
| Kinjo, F | 1 |
| Hanck, C | 1 |
| Holzer, BR | 1 |
| Chacín-Bonilla, L | 1 |
| Chanthavanich, P | 1 |
| Prarinyanuparp, V | 1 |
| Grove, DI | 1 |
| Lumsden, J | 1 |
| Northern, C | 1 |
| Saura, C | 1 |
| Roojee, N | 1 |
| Tran Manh Sung, R | 1 |
| Nielsen, PB | 1 |
| Agbo, K | 1 |
| Deniau, M | 1 |
| Pungpak, S | 1 |
| Bunnag, D | 1 |
| Radmoyos, B | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Efficacy and Safety of Ivermectin Versus Albendazole for Chronic Strongyloidiasis[NCT00765024] | Phase 3 | 90 participants (Actual) | Interventional | 2008-07-31 | Completed | ||
| Changes in HIV Viral Load in Patients Undergoing Treatment for Filarial Infection[NCT00344279] | 1,000 participants (Anticipated) | Observational | 2005-08-08 | Completed | |||
| Can Anthelminthic Treatment Delay the Progression of HIV? Randomised Open-label Trial Testing Presumptive Anthelminthic Treatment on Progression of HIV in ART-naïve HIV-positive Patients in a Rural African Setting With Presumed High Prevalence of Helminth[NCT00817713] | 295 participants (Actual) | Interventional | 2009-01-31 | Terminated (stopped due to Terminated prematurely due to recruitment difficulties. Expansion to more study sites not planned.) | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
18 reviews available for albendazole and Anguilluliasis
| Article | Year |
|---|---|
Ivermectin and albendazole coadministration: opportunities for strongyloidiasis control.
Topics: Albendazole; Animals; Anthelmintics; Helminths; Humans; Ivermectin; Soil; Strongyloides stercoralis; | 2022 |
Severe strongyloidiasis and systemic vasculitis: comorbidity, association or both? Case-based review.
Topics: Adrenal Cortex Hormones; Aged; Albendazole; Animals; Antinematodal Agents; Fatal Outcome; Feces; Gas | 2018 |
Ivermectin versus albendazole or thiabendazole for Strongyloides stercoralis infection.
Topics: Albendazole; Animals; Anthelmintics; Humans; Ivermectin; Randomized Controlled Trials as Topic; Stro | 2016 |
A Fatal Strongyloides Stercoralis Hyperinfection Syndrome in a Patient With Chronic kidney Disease: A Case Report and Literature Review.
Topics: Albendazole; Animals; Anthelmintics; Bronchoalveolar Lavage; China; Fatal Outcome; Hemorrhage; Human | 2016 |
[Clinical approach to imported eosinophilia].
Topics: Albendazole; Animals; Anthelmintics; Communicable Diseases, Imported; Eosinophilia; Humans; Ivermect | 2016 |
Hyperinfection strongyloidiasis in a liver transplant recipient treated with parenteral ivermectin.
Topics: Administration, Oral; Albendazole; Animals; Anthelmintics; Female; Graft Rejection; Humans; Immunosu | 2009 |
Detection and treatment of Strongyloides hyperinfection syndrome following lung transplantation.
Topics: Albendazole; Animals; Anthelmintics; Bronchoalveolar Lavage Fluid; Humans; Ivermectin; Lung Transpla | 2009 |
[An overview of Strongyloides stercoralis and its infections].
Topics: Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Humans; Immunocompromised Host; Ivermecti | 2009 |
Symptomatic chronic strongyloidiasis in children following treatment for solid organ malignancies: case reports and literature review.
Topics: Albendazole; Animals; Anthelmintics; Brain Neoplasms; Child, Preschool; Diarrhea; Enzyme-Linked Immu | 2012 |
Strongyloidiasis: a review of the evidence for Australian practitioners.
Topics: Albendazole; Animals; Anthelmintics; Antigens, Helminth; Child; Communicable Disease Control; Eviden | 2005 |
[Strongyloidosis. Part IX. Treatment].
Topics: Albendazole; Animals; Anticestodal Agents; Benzimidazoles; Cambendazole; Dose-Response Relationship, | 2002 |
[Therapeutic alternatives in case of failure of first-line treatment of intestinal helminthiasis in adults].
Topics: Albendazole; Ancylostomiasis; Anthelmintics; Artemether; Artemisinins; Benzimidazoles; Drug Resistan | 2006 |
Manifestations, diagnosis, and treatment of Strongyloides stercoralis infection.
Topics: Albendazole; Animals; Antinematodal Agents; Humans; Ivermectin; Risk Factors; Strongyloides stercora | 2007 |
Strongyloidiasis and other intestinal nematode infections.
Topics: Adult; Albendazole; Animals; Dogs; Female; Humans; Intestinal Diseases, Parasitic; Ivermectin; Male; | 1993 |
Albendazole.
Topics: Albendazole; Animals; Anthelmintics; Antiprotozoal Agents; Cysticercosis; Echinococcosis; Giardiasis | 1998 |
Case studies in international medicine.
Topics: Adolescent; Albendazole; Anti-Infective Agents; Antinematodal Agents; Antiplatyhelmintic Agents; Ant | 1999 |
[Disseminated strongyloidiasis].
Topics: Adrenal Cortex Hormones; Adult; Albendazole; Animals; Anthelmintics; Antinematodal Agents; Child; Hu | 2001 |
[Systemic strongyloidiasis. Review].
Topics: Albendazole; Animals; Disease Susceptibility; Humans; Immunocompromised Host; Intestinal Diseases, P | 1991 |
15 trials available for albendazole and Anguilluliasis
| Article | Year |
|---|---|
Rapid re-infection with soil-transmitted helminths after triple-dose albendazole treatment of school-aged children in Yunnan, People's Republic of China.
Topics: Albendazole; Ancylostomatoidea; Animals; Anthelmintics; Ascariasis; Ascaris lumbricoides; Child; Chi | 2013 |
The Lake Victoria Island Intervention Study on Worms and Allergy-related diseases (LaVIISWA): study protocol for a randomised controlled trial.
Topics: Albendazole; Animals; Anthelmintics; Biomarkers; Clinical Protocols; Dermatitis, Atopic; Drug Admini | 2015 |
Tribendimidine and albendazole for treating soil-transmitted helminths, Strongyloides stercoralis and Taenia spp.: open-label randomized trial.
Topics: Administration, Oral; Adolescent; Albendazole; Animals; Anthelmintics; Child; Child, Preschool; Chin | 2008 |
Efficacy and safety of single and double doses of ivermectin versus 7-day high dose albendazole for chronic strongyloidiasis.
Topics: Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Feces; Female; Humans; Ivermect | 2011 |
Prevalence of strongyloides in Northern Thailand and treatment with ivermectin vs albendazole.
Topics: Albendazole; Animals; Anthelmintics; Feces; Female; Humans; Ivermectin; Liver Function Tests; Male; | 2005 |
Concomitant parasitism: bancroftian filariasis and intestinal helminths and response to albendazole.
Topics: Adolescent; Adult; Albendazole; Animals; Ascariasis; Ascaris; Elephantiasis, Filarial; Female; Filar | 2005 |
Comparison of albendazole regimen for prophylaxis of strongyloides hyperinfection in nephrotic syndrome patients on long-term steroids in Cambodia.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Cambodia; Chemoprevention; Humans; Middle Ag | 2005 |
Randomized comparative trial of two high-dose albendazole regimens for uncomplicated human strongyloidiasis.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Child; Drug Administration Schedule; F | 2006 |
Efficacy and safety of a single-dose veterinary preparation of ivermectin versus 7-day high-dose albendazole for chronic strongyloidiasis.
Topics: Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Feces; Femal | 2008 |
Albendazole: placebo-controlled study in 870 patients with intestinal helminthiasis.
Topics: Adolescent; Adult; Aged; Albendazole; Ancylostomiasis; Anthelmintics; Ascariasis; Benzimidazoles; Ch | 1983 |
Albendazole: a new broad spectrum anthelmintic. Double-blind multicenter clinical trial.
Topics: Adolescent; Adult; Albendazole; Ancylostomiasis; Ascariasis; Benzimidazoles; Cestode Infections; Chi | 1982 |
A comparative trial of a single-dose ivermectin versus three days of albendazole for treatment of Strongyloides stercoralis and other soil-transmitted helminth infections in children.
Topics: Adolescent; Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; Ascaris lumbricoides; Chi | 1996 |
A randomized comparative study of albendazole and thiabendazole in chronic strongyloidiasis.
Topics: Adult; Albendazole; Antinematodal Agents; Chronic Disease; Eosinophils; Feces; Humans; Leukocyte Cou | 1995 |
Comparative studies on the efficacy of three anthelminthics on treatment of human strongyloidiasis in Okinawa, Japan.
Topics: Adult; Aged; Aged, 80 and over; Albendazole; Animals; Antinematodal Agents; Drug Administration Sche | 2000 |
[Clinical study of albendazole therapy for strongyloidiasis].
Topics: Adult; Aged; Albendazole; Female; HTLV-I Antibodies; Humans; Male; Middle Aged; Strongyloidiasis | 1992 |
115 other studies available for albendazole and Anguilluliasis
| Article | Year |
|---|---|
Case Report: Challenges for the Diagnosis and Treatment of Strongyloides stercoralis in Chronic Obstructive Pulmonary Disease Patients.
Topics: Adrenal Cortex Hormones; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Eosinophilia; | 2021 |
Strongyloides stercoralis hyperinfection syndrome: a known entity in an unknown provenance.
Topics: Albendazole; Animals; Humans; Ivermectin; Male; Middle Aged; Strongyloides stercoralis; Strongyloidi | 2022 |
Current pharmacotherapeutic strategies for Strongyloidiasis and the complications in its treatment.
Topics: Albendazole; Female; Humans; Ivermectin; Lactation; Soil; Strongyloidiasis | 2022 |
Topics: Aged; Albendazole; Animals; Eosinophilia; Humans; Ivermectin; Larva; Male; Strongyloides stercoralis | 2022 |
Strongyloides hyperinfection syndrome and cytomegalovirus infection in a patient with type II diabetes mellitus.
Topics: Albendazole; Animals; Anti-Bacterial Agents; Cytomegalovirus Infections; Diabetes Mellitus, Type 2; | 2023 |
Strongyloides stercoralis Hyperinfection and Intractable Pulmonary Hemorrhage.
Topics: Albendazole; Animals; Bronchoalveolar Lavage; Child; Glomerulonephritis; Hemorrhage; Humans; India; | 2020 |
Topics: Adult; Aged; Albendazole; Animals; Feces; HIV Seropositivity; Homosexuality, Male; Humans; Ivermecti | 2020 |
A Case of Rheumatoid Arthritis with
Topics: Abdominal Pain; Aged, 80 and over; Agricultural Workers' Diseases; Albendazole; Animals; Anthelminti | 2020 |
Subcutaneous ivermectin for the treatment of the hyperinfection syndrome by Strongyloides stercoralis
Topics: Adult; Albendazole; Animals; Anthelmintics; Bronchoalveolar Lavage Fluid; Female; Humans; Immunocomp | 2020 |
Strongyloides Superinfection After Liver Transplantion.
Topics: Albendazole; Animals; Antiparasitic Agents; Drug Therapy, Combination; Humans; Ivermectin; Liver Tra | 2021 |
A case of Strongyloides hyperinfection syndrome in the setting of persistent eosinophilia but negative serology.
Topics: Albendazole; Animals; Antibodies, Helminth; Antiparasitic Agents; Bronchoalveolar Lavage Fluid; Enzy | 2017 |
Albendazole and ivermectin for the control of soil-transmitted helminths in an area with high prevalence of Strongyloides stercoralis and hookworm in northwestern Argentina: A community-based pragmatic study.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; | 2017 |
Management of severe strongyloidiasis attended at reference centers in Spain.
Topics: Adult; Aged; Albendazole; Animals; Antiparasitic Agents; Communicable Diseases, Imported; Comorbidit | 2018 |
Successful Treatment of Strongyloides stercoralis Hyperinfection in a Kidney Transplant Recipient: Case Report.
Topics: Albendazole; Animals; Antiparasitic Agents; Biopsy; Drug Therapy, Combination; Eosinophilia; Humans; | 2018 |
Urinary Tract Infection by Strongyloides stercoralis: A Case Report.
Topics: Aged; Albendazole; Animals; Antinematodal Agents; Feces; Humans; Hydronephrosis; Kidney Calculi; Mal | 2018 |
Case Report: Ivermectin and Albendazole Plasma Concentrations in a Patient with Disseminated Strongyloidiasis on Extracorporeal Membrane Oxygenation and Continuous Renal Replacement Therapy.
Topics: Albendazole; Animals; Anthelmintics; Extracorporeal Membrane Oxygenation; Humans; Ivermectin; Larva; | 2018 |
In-vitro Anthelmintic Effects of Aqueous and Ethanolic Extracts of Marrubium vulgare Leaves Against Bovine Digestive Strongyles.
Topics: Albendazole; Algeria; Animals; Anthelmintics; Cattle; Cattle Diseases; Marrubium; Phytotherapy; Plan | 2018 |
Central Nervous System Strongyloides Stercoralis. A Case Report.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Brain; Epilepsy; Female; Humans; Strongyloides ster | 2020 |
Effectiveness of several anthelmintics to control a Strongyloides sp. outbreak in Creole-de-Guadeloupe male kids aged 7 months.
Topics: Age Factors; Albendazole; Animals; Anthelmintics; Disease Outbreaks; Drug Resistance; Feces; Goat Di | 2018 |
Hypereosinophilia and severe bone disease in an African child: an unexpected diagnosis.
Topics: Adrenal Cortex Hormones; Africa; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Bone Dis | 2019 |
Imported strongyloidiasis: Data from 1245 cases registered in the +REDIVI Spanish Collaborative Network (2009-2017).
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Child; Child, Presc | 2019 |
[About a Case of Febrile Gastroenteritis Due to Strongyloidiasis in a Gabonese Patient Treated for Lupus].
Topics: Adrenal Cortex Hormones; Adult; Albendazole; Antiparasitic Agents; Biopsy; Duodenum; Feces; Female; | 2019 |
Disseminated strongyloidiasis complicated by alveolar hemorrhage, meningitis, and septic shock treated with albendazole and subcutaneous ivermectin.
Topics: Albendazole; Animals; Anthelmintics; Hemorrhage; Humans; Ivermectin; Male; Meningitis; Middle Aged; | 2019 |
[Strongyloidosis caused Loeffler's syndrome in an immunosuppressed patient who uses cronic steroid].
Topics: Abdominal Pain; Albendazole; Animals; Antinematodal Agents; Diarrhea; Feces; Glucocorticoids; Humans | 2013 |
Triple worm infestation in an HIV-infected patient.
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Anthelmintics; Appendicitis; Dic | 2013 |
"Surprise" in the evolution of chronic membranoproliferative glomerulonephritis associated with severe strongyloidiasis under corticotherapy: "hygienic paradox"?
Topics: Albendazole; Animals; Antiparasitic Agents; Biopsy; Duodenoscopy; Female; Gastrointestinal Hemorrhag | 2013 |
Strongyloides stercoralis transmission by kidney transplantation in two recipients from a common donor.
Topics: Adult; Albendazole; Animals; Ganciclovir; Humans; Immunocompromised Host; Ivermectin; Kidney Transpl | 2013 |
[Strongyloides stercoralis in a patient with ankylosing spondylitis: case report].
Topics: Adrenal Cortex Hormones; Albendazole; Animals; Anti-Inflammatory Agents; Antibodies, Monoclonal; Ant | 2013 |
Fatal Strongyloides hyper-infection in a patient with myasthenia gravis.
Topics: Albendazole; Antinematodal Agents; Endemic Diseases; Fatal Outcome; Humans; Immunocompromised Host; | 2014 |
Diffuse alveolar haemorrhage and severe hypoxemia from Strongyloides stercoralis hyperinfection syndrome.
Topics: Adult; Albendazole; Animals; Anthelmintics; Female; Hemorrhage; Humans; Ivermectin; Pulmonary Alveol | 2015 |
Prevalence of soil-transmitted helminths after mass albendazole administration in an indigenous community of the Manu jungle in Peru.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Ascariasis; Child; Child, Preschool; Cross-S | 2014 |
Gastrointestinal: Strongyloides stercoralis infestation.
Topics: Albendazole; Animals; Anthelmintics; Endoscopy, Gastrointestinal; Female; Humans; Intestinal Disease | 2014 |
Use of dried blood spots to define antibody response to the Strongyloides stercoralis recombinant antigen NIE.
Topics: Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Antigens, Helminth; Australia; Child; Chi | 2014 |
Control of soil-transmitted helminthiasis in Yunnan province, People's Republic of China: experiences and lessons from a 5-year multi-intervention trial.
Topics: Albendazole; Ancylostomatoidea; Animals; Anthelmintics; Ascariasis; Ascaris lumbricoides; China; Fec | 2015 |
Strongyloides stercoralis infection in kidney transplant recipients.
Topics: Adult; Albendazole; Animals; Anthelmintics; Female; Humans; Immunosuppression Therapy; Kidney Transp | 2015 |
Comorbid gastric adenocarcinoma and gastric and duodenal Strongyloides stercoralis infection: a case report.
Topics: Adenocarcinoma; Aged, 80 and over; Albendazole; Animals; Anthelmintics; DNA, Helminth; DNA, Ribosoma | 2015 |
Strongyloidiasis in a diabetic patient accompanied by gastrointestinal stromal tumor: cause of eosinophilia unresponsive to steroid therapy.
Topics: Aged; Albendazole; Animals; Diabetes Mellitus, Type 2; Eosinophilia; Female; Gastrointestinal Stroma | 2015 |
Multiple parasitic infections in a cardiac transplant recipient.
Topics: Abdominal Pain; Adolescent; Albendazole; Animals; Anthelmintics; Diarrhea; Feces; Female; Heart Tran | 2015 |
[Malignant anguillulosis of fatal outcome in pemphigus vegetans].
Topics: Adult; Albendazole; Animals; Anthelmintics; Colistin; Eosinophilia; Fatal Outcome; Female; Hemoptysi | 2015 |
IBD or strongyloidiasis?
Topics: Adult; Albendazole; Anthelmintics; Diagnosis, Differential; Humans; Immunosuppressive Agents; Inappr | 2016 |
IL-10- and TGFβ-mediated Th9 Responses in a Human Helminth Infection.
Topics: Adolescent; Adult; Albendazole; Antiparasitic Agents; Case-Control Studies; Female; Gene Expression | 2016 |
Treatment for chronic Strongyloides stercoralis infection: moderate-to-low evidence shows that ivermectin is more effective and tolerable than albendazole and thiabendazole, respectively.
Topics: Albendazole; Animals; Humans; Ivermectin; Strongyloides stercoralis; Strongyloidiasis; Thiabendazole | 2016 |
Woman With Dyspnea and Abdominal Rash.
Topics: Abdominal Pain; Albendazole; Antiparasitic Agents; Black People; Dyspnea; Endoscopy, Digestive Syste | 2016 |
Multiorgan Dysfunction Syndrome from Strongyloides stercoralis Hyperinfection in a Patient with Human T-Cell Lymphotropic Virus-1 Coinfection After Initiation of Ivermectin Treatment.
Topics: Albendazole; Animals; Antiparasitic Agents; Coinfection; Enterocolitis, Pseudomembranous; Gram-Negat | 2016 |
[Pulmonary strongyloidiasis].
Topics: Albendazole; Animals; Antiparasitic Agents; Female; Humans; Ivermectin; Lung Diseases, Parasitic; Mi | 2016 |
Anemia During Pregnancy-The Enemies Within.
Topics: Administration, Oral; Adult; Albendazole; Anemia; Animals; Female; Hematocrit; Hemoglobins; Humans; | 2017 |
An unusual endoscopic diagnosis for acute epigastric pain.
Topics: Abdominal Pain; Acute Disease; Adult; Albendazole; Animals; Biopsy, Needle; Duodenoscopy; Female; Hu | 2008 |
[Case report: strongyloidiosis with chronic abdominal pain].
Topics: Abdominal Pain; Albendazole; Animals; Anthelmintics; Child; Chronic Disease; Diagnosis, Differential | 2008 |
[Transient pruritus in an Ethiopean adoptee in Austria].
Topics: Adoption; Albendazole; Animals; Anthelmintics; Austria; Buttocks; Child, Preschool; Diagnosis, Diffe | 2008 |
A case of fatal strongyloidiasis in a patient with chronic lymphocytic leukemia and molecular characterization of the isolate.
Topics: Aged; Albendazole; Animals; Anthelmintics; Fatal Outcome; Humans; Ivermectin; Larva; Leukemia, Lymph | 2008 |
Disseminated strongyloidiasis complicating glioblastoma therapy: a case report.
Topics: Albendazole; Antiprotozoal Agents; Diffusion Magnetic Resonance Imaging; Female; Glioblastoma; Human | 2009 |
Treatment of Strongyloides stercoralis hyperinfection-associated septic shock and acute respiratory distress syndrome with drotrecogin alfa (activated) in a renal transplant recipient.
Topics: Aged, 80 and over; Albendazole; Animals; Anti-Infective Agents; Drug Therapy, Combination; Female; F | 2009 |
Persistent eosinophilia and Strongyloides infection in Montagnard refugees after presumptive albendazole therapy.
Topics: Albendazole; Animals; Anthelmintics; Eosinophilia; Humans; Ivermectin; North Carolina; Refugees; Str | 2009 |
Strongyloides stercoralis hyperinfection transmitted by liver allograft in a transplant recipient.
Topics: Aged; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Humans; Ivermectin; Liver Transplan | 2009 |
[Weight loss and fever in a 72-year-old man].
Topics: Aged; Albendazole; Anthelmintics; Anticestodal Agents; Antineoplastic Combined Chemotherapy Protocol | 2010 |
Eosinophilia secondary to strongyloides in Rhode Island.
Topics: Adult; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Blastocystis hominis; Blastocystis | 2010 |
Albendazole stimulates the excretion of strongyloides stercoralis Larvae in stool specimens and enhances sensitivity for diagnosis of strongyloidiasis.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Child; Feces; Humans; Larva; Middle Ag | 2010 |
Strongyloides stercoralis hyperinfection in a patient with rheumatoid arthritis and bronchial asthma: a case report.
Topics: Aged; Albendazole; Animals; Antinematodal Agents; Arthritis, Rheumatoid; Asthma; Drug Therapy, Combi | 2010 |
Comment about nephrotic syndrome in association with strongyloidiasis.
Topics: Adult; Albendazole; Humans; Ivermectin; Male; Nephrotic Syndrome; Strongyloidiasis; Trimethoprim, Su | 2011 |
[Severe pneumonia in a patient infected with human immunodeficiency virus (HIV)].
Topics: Adult; AIDS-Related Opportunistic Infections; Albendazole; Animals; Anthelmintics; Bronchoalveolar L | 2012 |
Effects of infection intensity with Strongyloides papillosus and albendazole treatment on development of oxidative/nitrosative stress in sheep.
Topics: Albendazole; Animals; Feces; Female; Oxidation-Reduction; Oxidative Stress; Proteins; Sheep; Sheep D | 2012 |
Nonresponsive celiac disease due to Strongyloides stercoralis infestation.
Topics: Albendazole; Animals; Celiac Disease; Diagnosis, Differential; Diet, Gluten-Free; Humans; Male; Midd | 2012 |
Strongyloidiasis in a nonagenarian who previously worked in conservancy services.
Topics: Aged, 80 and over; Albendazole; Antinematodal Agents; Diarrhea; Eosinophilia; Female; Hong Kong; Hum | 2013 |
[Disseminated strongyloidiasis, a rare cause of multiple organ failure].
Topics: Aged; Albendazole; Animals; Diagnosis, Differential; Drug Therapy, Combination; Female; Humans; Iver | 2002 |
[Thirty-two-year-old male patient with recurrent abdominal pain and slight amylase elevation].
Topics: Abdominal Pain; Adult; Albendazole; Amylases; Animals; Anthelmintics; Bile Duct Diseases; Biomarkers | 2002 |
A case of Strongyloides stercoralis and mesenteric tuberculous infection with acute abdominal pain in an HIV-positive patient.
Topics: Adult; Albendazole; Animals; Anthelmintics; Antitubercular Agents; Female; HIV Infections; Humans; L | 2002 |
[Report of a case with albendazole-resistant Strongyloides stercoralis infection].
Topics: Albendazole; Animals; Anthelmintics; Drug Resistance; Female; Humans; Middle Aged; Strongyloides ste | 2000 |
A case of gastric strongyloidiasis in a Korean patient.
Topics: Aged; Albendazole; Animals; Anthelmintics; Feces; Female; Humans; Intestines; Korea; Male; Strongylo | 2003 |
Pulmonary strongyloidiasis presenting as chronic bronchitis leading to interlobular septal fibrosis and cured by treatment.
Topics: Aged; Albendazole; Anthelmintics; Australia; Bronchitis, Chronic; Humans; Ivermectin; Male; Pulmonar | 2003 |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
Topics: Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progres | 2004 |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
Topics: Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progres | 2004 |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
Topics: Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progres | 2004 |
Helminth infection is not associated with faster progression of HIV disease in coinfected adults in Uganda.
Topics: Adult; Albendazole; Ancylostomatoidea; Animals; Anthelmintics; CD4 Lymphocyte Count; Disease Progres | 2004 |
The cost-effectiveness of ivermectin vs. albendazole in the presumptive treatment of strongyloidiasis in immigrants to the United States.
Topics: Albendazole; Animals; Anthelmintics; Antinematodal Agents; Cohort Studies; Cost-Benefit Analysis; De | 2004 |
Disseminated strongyloidiasis successfully treated with extended duration ivermectin combined with albendazole: a case report of intractable strongyloidiasis.
Topics: Albendazole; Animals; Anthelmintics; Drug Therapy, Combination; Feces; Female; Humans; Intestinal Di | 2004 |
[Recurrent strongyloidiasis as an indicator of HTLV-1 infection].
Topics: Albendazole; Animals; Anthelmintics; Feces; Fever; Germany; Guinea; Headache; HTLV-I Infections; Hum | 2005 |
Comment on: Strongyloidiasis: a mistaken diagnosis and a fatal outcome in a patient with diarrhoea.
Topics: Albendazole; Antiparasitic Agents; Diagnostic Errors; Diarrhea; Eosinophilia; Humans; Ivermectin; Ma | 2006 |
Parenteral administration of ivermectin in a patient with disseminated strongyloidiasis.
Topics: Adult; Albendazole; Animals; Anthelmintics; Antiparasitic Agents; Cerebrospinal Fluid; Humans; Injec | 2005 |
Helminth infections in British troops following an operation in Sierra Leone.
Topics: Albendazole; Anthelmintics; Eosinophilia; Feces; Gastroenteritis; Helminthiasis; Hookworm Infections | 2006 |
Utility of serological follow-up of chronic strongyloidiasis after anthelminthic chemotherapy.
Topics: Adolescent; Adult; Aged; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Chronic Disease; | 2006 |
Mazzotti reaction after presumptive treatment for schistosomiasis and strongyloidiasis in a Liberian refugee.
Topics: Adolescent; Albendazole; Animals; Anthelmintics; Humans; Ivermectin; Liberia; Male; Praziquantel; Re | 2006 |
[Acute diarrhea in a patient with rheumatoid arthritis].
Topics: Acute Disease; Albendazole; Animals; Anthelmintics; Arthritis, Rheumatoid; Diarrhea; Gastritis; Huma | 2006 |
[Strongyloidosis--a case report].
Topics: Albendazole; Animals; Anthelmintics; Biomarkers; Eosinophils; Heart; Humans; Lung; Male; Middle Aged | 2001 |
[Strongyloides stercoralis in a patient complaining of chronic diarrhea].
Topics: Abdominal Pain; Adult; Albendazole; Animals; Anthelmintics; Chronic Disease; Diarrhea; Feces; Humans | 2006 |
Risk factors for strongyloidiasis hyperinfection and clinical outcomes.
Topics: Albendazole; Anthelmintics; Chronic Disease; Female; Humans; Immunocompromised Host; Ivermectin; Mal | 2006 |
[Nephrotic syndrome and Gram-negative sepsis in a patient with strongyloidiasis: a case report].
Topics: Adult; Albendazole; Animals; Anthelmintics; Anti-Bacterial Agents; Bacteremia; Ecuador; Endemic Dise | 2007 |
Disseminated strongyloidiasis and cytomegalovirus infection in a patient with anaplastic large cell lymphoma.
Topics: Adult; Albendazole; Anthelmintics; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; | 2007 |
Respiratory hyperinfection with Strongyloides stercoralis in a patient with renal failure.
Topics: Administration, Oral; Adult; Albendazole; Animals; Anthelmintics; Antibodies, Antineutrophil Cytopla | 2007 |
Eosinophilia in a patient from South America.
Topics: Albendazole; Animals; Antiparasitic Agents; Emigrants and Immigrants; Eosinophilia; Guyana; Humans; | 2008 |
Strongyloides stercoralis isolated by agar plate culture.
Topics: Albendazole; Animals; Child; Humans; Male; Sri Lanka; Strongyloides stercoralis; Strongyloidiasis | 2007 |
[Strongyloidiosis and Loeffler's syndrome detected in a patient who used a short term steroid treatment].
Topics: Albendazole; Animals; Anthelmintics; Feces; Glucocorticoids; Humans; Immunocompromised Host; Male; P | 2008 |
Control of Filaroides hirthi in commercially reared beagle dogs.
Topics: Albendazole; Animals; Antinematodal Agents; Benzimidazoles; Dog Diseases; Dogs; Female; Lung Disease | 1982 |
[Albendazole in the treatment of strongyloidiasis. Report of 66 cases].
Topics: Adult; Albendazole; Anthelmintics; Benzimidazoles; Female; Humans; Male; Middle Aged; Strongyloidias | 1982 |
Fulminating strongyloidiasis complicating Indian kala-azar.
Topics: Adolescent; Adult; Albendazole; Animals; Anthelmintics; Diarrhea; Female; Humans; India; Leishmanias | 1995 |
[Intestinal strongyloidiasis and isosporiasis in AIDS].
Topics: Acquired Immunodeficiency Syndrome; Albendazole; Animals; Coccidiosis; Humans; Isospora; Male; Middl | 1994 |
[Nine cases of strongyloidiasis in Korea].
Topics: Aged; Albendazole; Animals; Arthritis; Female; Humans; Male; Mebendazole; Middle Aged; Strongyloides | 1994 |
The efficacy of two electron transport inhibitors (720C80 and 993C76) on murine strongyloidiasis: a comparison with albendazole.
Topics: Albendazole; Animals; Antiprotozoal Agents; Female; Naphthoquinones; Rats; Rats, Sprague-Dawley; Str | 1993 |
Albendazole is effective treatment for chronic strongyloidiasis.
Topics: Aged; Albendazole; Chronic Disease; Diarrhea; Enzyme-Linked Immunosorbent Assay; Feces; Humans; Male | 1993 |
[Recurrent dyspnea attacks, urticaria, epigastric symptoms and eosinophilia].
Topics: Adult; Albendazole; Anthelmintics; Dyspepsia; Dyspnea; Eosinophilia; Feces; Female; Humans; Intestin | 1997 |
Intestinal strongyloidiasis--a rare opportunistic infection.
Topics: Adult; Albendazole; Animals; Anthelmintics; Diarrhea; Fatal Outcome; Female; Humans; Immunosuppressi | 1997 |
[Strongyloides stercoralis infection in a patient with AIDS and non-Hodgkin lymphoma].
Topics: AIDS-Related Opportunistic Infections; Albendazole; Animals; Anthelmintics; Duodenum; Feces; Germany | 1998 |
A case of Strongyloides stercoralis infection.
Topics: Albendazole; Animals; Anthelmintics; Feces; Female; Humans; Intestinal Diseases, Parasitic; Larva; M | 1999 |
Treatment of intestinal parasites in immigrants.
Topics: Albendazole; Animals; Antiparasitic Agents; Decision Support Techniques; Emigration and Immigration; | 1999 |
Production of a high level of specific IgG4 antibody associated with resistance to albendazole treatment in HLA-DRB1*0901-positive patients with strongyloidiasis.
Topics: Aged; Albendazole; Alleles; Animals; Anthelmintics; Antibodies, Helminth; Drug Resistance; Enzyme-Li | 1999 |
[A case of autochotonous anguilluliasis].
Topics: Albendazole; Antinematodal Agents; Body Weight; Drug Administration Schedule; Humans; Ivermectin; St | 1999 |
Strongyloides stercoralis infection and chronological changes of other soil-transmitted helminthiases in an endemic area of southern Thailand.
Topics: Albendazole; Animals; Antinematodal Agents; Ascariasis; Child; Endemic Diseases; Feces; Helminthiasi | 2000 |
Community control studies on Strongyloides infection in a model island of Okinawa, Japan.
Topics: Adult; Albendazole; Animals; Antinematodal Agents; Feces; Female; Humans; Ivermectin; Japan; Male; M | 2000 |
[Strongyloides stercoralis infestation in patients with chronic obstructive lung disease in Vega del Segura (Murcia). 3 case reports].
Topics: Aged; Aged, 80 and over; Albendazole; Animals; Anthelmintics; Antinematodal Agents; Feces; Humans; L | 2001 |
Reduced efficacy of treatment of strongyloidiasis in HTLV-I carriers related to enhanced expression of IFN-gamma and TGF-beta1.
Topics: Aged; Albendazole; Animals; Anthelmintics; Antibodies, Helminth; Feces; Female; Gene Expression Regu | 2002 |
Strongyloides stercoralis hyperinfection in Israel--a case report.
Topics: Albendazole; Animals; Carcinoma, Squamous Cell; Humans; Lung Neoplasms; Lymphatic Metastasis; Male; | 1992 |
[A case of strongyloidiasis accompanied by duodenal ulcer].
Topics: Albendazole; Animals; Bismuth; Duodenal Ulcer; Humans; Male; Middle Aged; Strongyloides stercoralis; | 1992 |
[Strongyloidiasis under immunosuppressive therapy].
Topics: Albendazole; Autoimmune Diseases; Drug Therapy, Combination; Humans; Immunosuppressive Agents; Intes | 1992 |
Repeated doses of albendazole against strongyloidiasis in Thai children.
Topics: Albendazole; Child; Child, Preschool; Drug Administration Schedule; Female; Humans; Male; Strongyloi | 1989 |
Efficacy of albendazole against Strongyloides ratti and S. stercoralis in vitro, in mice, and in normal and immunosuppressed dogs.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Dogs; Feces; Female; Immune Tolerance; Male; Mi | 1988 |
Albendazole and thiabendazole in murine strongyloidiasis.
Topics: Albendazole; Animals; Anthelmintics; Benzimidazoles; Female; Larva; Rats; Rats, Inbred Strains; Stro | 1987 |
Treatment of strongyloides stercoralis with albendazole. A cure rate of 86 per cent.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Benzimidazoles; Child; Child, Preschool; Drug A | 1987 |
[Anguillospermia resistant to treatment. Apropos of a case diagnosed in Togo].
Topics: Adult; Albendazole; Benzimidazoles; Humans; Infertility, Male; Male; Spermatozoa; Strongyloidiasis; | 1987 |
Albendazole in the treatment of strongyloidiasis.
Topics: Adolescent; Adult; Aged; Albendazole; Anthelmintics; Benzimidazoles; Drug Administration Schedule; F | 1987 |